Answers are grounded in this paper and cite their sources.
Present study was designed to screen the role of Phoenix dactylifera L. (P.dactylifera) in CNS disorders.All the records were summarized according to PRISMA statement of systematic reviews.By applying identification, exclusion, eligibility and inclusion criterias, 17 original research articles were selected.In these studies, P. dactylifera was used as either long term dietary supplementation or aqueous or ethanolic or methanolic extracts.These studies reported different activities such as anti-Alzheimer's, anticonvulsant, cerebral antiischemic, neuroprotective, anxiolytic, nootropic and antipsychotic.Mechanisms underlying anti-Alzheimer's activity of P. dactylifera were antioxidant, anxiolytic, cholinomimetic and anti-inflammatory actions.Anticonvulsant activity was due to GABA facilitatory action and blocking of NMDA action.Antioxidant nature of flavonoids, tannins and phenols of P. dactylifera showed neuroprotective and cerebral anti-ischemic actions.whereas antipsychotic actions were due to decreased serotonergic and dopaminergic transmissions and increased cholinergic transmission.This systematic study successfully establishes and supports protective role of P. dactylifera in treatment of CNS related disorders and put forth the path to carry out the meta-analyses for increasing the use of safer plant based remedies.
No takes yet. Share an insight, caveat, or question.
Uddin et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: